Publications by authors named "Chengxue Yi"

Claim this Profile
C
Curcumin Ameliorates DSS-Induced Colitis in Mice Through Modulation of Gut Microbiota and Metabolites.
Chengxue Yi, Yuxuan Xia, Jiajing Yan, Wen Xia, Haoyu Wang

Life (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human umbilical cord mesenchymal stem cell-derived exosomes repair IBD by activating the SIRT1-FXR pathway in macrophages.
Mengjiao Zhou, Bing Pei, Peipei Cai, Chengxue Yi, Francis Atim Akanyibah

Stem Cell Res Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer.
Pengfei Zhang, Bing Pei, Chengxue Yi, Francis Atim Akanyibah, Fei Mao

Biochim Biophys Acta Mol Basis Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative and quantitative analysis of major components in Abelmoschus manihot flowers treated with different drying methods using UHPLC Q-exactive MS and HPLC-PDA.
Shaoqing Zhu, Wei Wang, Xiang Liu, Chengxue Yi, Li Li

J Pharm Biomed Anal· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.
Muhammad Azhar Ud Din, Yan Lin, Changkun Lyu, Chengxue Yi, Anning Fang

Mol Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human umbilical cord mesenchymal stem cells derived-exosomes alleviate LPS-induced cervical inflammation and epithelial-mesenchymal transition.
Chengxue Yi, Haoyu Wang, Muhammad Azhar Ud Din, Yuxuan Xia, Francis Atim Akanyibah

Am J Transl Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of the gut microbiota and its application in inflammatory bowel disease.
Xiu Wang, Jianhua Peng, Peipei Cai, Yuxuan Xia, Chengxue Yi, Francis Atim Akanyibah

Biomed Pharmacother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HucMSC-Ex alleviates DSS-induced colitis in mice by decreasing mast cell activation via the IL-33/ST2 axis.
Zhiping Wei, Xiaohua Tang, Chengxue Yi, Dickson Kofi Wiredu Ocansey, Fei Mao

Am J Transl Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease.
Ziyue Liu, Yaqin Zhang, Tao Jin, Chengxue Yi, Dickson Kofi Wiredu Ocansey

Int Immunopharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Chain Fatty Acids Weaken Ox-LDL-Induced Cell Inflammatory Injury by Inhibiting the NLRP3/Caspase-1 Pathway and Affecting Cellular Metabolism in THP-1 Cells.
Chengxue Yi, Wen Sun, Longkun Ding, Man Yan, Chang Sun

Molecules· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer.
Mengjiao Zhou, Danfeng Wang, Xiang Li, Ying Cao, Chengxue Yi

Front Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers.
Naijian Wang, Bing Pei, Xinyi Yuan, Chengxue Yi, Dickson Kofi Wiredu Ocansey

Front Bioeng Biotechnol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease.
Xinwei Xu, Dickson Kofi Wiredu Ocansey, Sanhua Hang, Bo Wang, Samuel Amoah, Chengxue Yi

Gut Pathog· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three main short-chain fatty acids inhibit the activation of THP-1 cells by Mycoplasma pneumoniae.
Xia Wen, Dai Xiaoyue, Ding Longkun, Xi Yue, Yan Man, Yi Chengxue

Biosci Biotechnol Biochem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mycoplasma pneumoniae toxin of community-acquired respiratory distress syndrome (CARDS) promotes autophagy of THP-1 cells and activates NLRP3 inflammasomes].
Wen Xia, Xiaoyue Dai, Liang Wu, Chengxue Yi, Zhiqing Zou

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous HPLC determination of ergosterol and 22,23-dihydroergosterol in Flammulina velutipes sterol-loaded microemulsion.
Shanshan Tong, Hui Zhong, Chengxue Yi, Xia Cao, Caleb Kesse Firempong, Yingshu Feng

Biomed Chromatogr· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced oral bioavailability and tissue distribution of a new potential anticancer agent, Flammulina velutipes sterols, through liposomal encapsulation.
Chengxue Yi, Min Fu, Xia Cao, Shanshan Tong, Qianfeng Zheng, Xinyi Jiang

J Agric Food Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic effect of novel Flammulina velutipes sterols and its oral bioavailability via mixed micellar nanoformulation.
Chengxue Yi, Chaonan Sun, Shanshan Tong, Xia Cao, Yingshu Feng, Xinyi Jiang

Int J Pharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced oral bioavailability of a sterol-loaded microemulsion formulation of Flammulina velutipes, a potential antitumor drug.
Chengxue Yi, Hui Zhong, Shanshan Tong, Xia Cao, Caleb K Firempong, Yingshu Feng

Int J Nanomedicine· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Nanoscale drug carriers for traditional Chinese medicine research and development].
Cheng-xue Yi, Jiang-nan Yu, Xi-ming Xu

Zhongguo Zhong Yao Za Zhi· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis